Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2026-02-28 @ 12:55 PM
Study NCT ID:
NCT02213133
Status:
TERMINATED
Last Update Posted:
2023-01-26
First Post:
2014-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KCP-330-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None